Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Audit MicroControls received 510(k) clearance from the FDA, allowing the addition of assayed lithium to Audit’s therapeutic drug monitoring daily quality control and calibration verification/linearity kits. With the addition of lithium, Audit’s TDM linearity kit will have five levels and 14 assayed analytes and the control will have three levels and 13 assayed analytes.
Diagnostica Stago expanded its line of automated hemostasis analyzers with the launch of the STA Compact Max Hemostasis Testing System, a coagulation testing solution for mid- to high-volume laboratories. The new touchscreen user interface enables intuitive operation at any skill level, and the system’s integrated expert module offers autoverification, expert rules, an advanced QC system, and electronic lot conversion.
Beckman Coulter Life Sciences’ new reagent kits for intracellular staining minimize sample manipulation for a streamlined workflow. Developed for use on Beckman Coulter’s Gallios and Navios series flow cytometers and compatible with all Beckman fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.
Gold Standard Diagnostics announced FDA 510(k) clearance of its 25-OH vitamin D, total ELISA. This assay correlates with established liquid chromatography/mass spectrometry, enzyme immunoassay, and chemiluminescence methods, and offers high sensitivity and specificity over a wide dynamic range. The assay can be automated on a variety of instruments, providing a cost-effective vitamin D testing option even at lower volumes.
Seegene’s novel real-time array technology is designed to accelerate the development of point-of-care testing by eliminating steps that normally follow PCR amplification, and that are required for conventional arrays. The new technology unifies all the steps into one. There is no size limitation for the PCR amplicon, and the array technology requires no asymmetric PCR, denaturation of the PCR amplicon, target specific primer extension, signal amplification, or washing step.
Alere has received FDA approval to market its Alere Determine HIV-1/2 Ag/Ab Combo in the United States. The Alere Determine HIV-1/2 Ag/Ab Combo is a rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear days after infection and prior to HIV-1/2 antibodies.
BD Diagnostics and Diagenode announced the European-only launch of the Diagenode Bordetella pertussis/parapertussis real-time PCR kit for use on the BD Max system. The kit has been CE-marked and validated to run on the BD Max system using the BD Max ExK DNA-1 extraction kit, an open-system reagent. BD Diagnostics, 800-675-0938 Diagenode, 862-209-4680
PolyScience’s performance programmable circulating baths make it simple to create and run multi-step ramp and soak temperature programs as well as frequently used single temperature testing protocols. The baths have an icon-driven touchscreen display that makes it easy to select and set operational parameters. A built-in electronic keypad speeds and simplifies the entry of text and numerical values. Available in refrigerating/heating and heat-only models, PolyScience performance programmable circulating baths control bath temperatures from −40°C to 200°C with ±0.005°C stability and
Qiagen announced a partnership with Exosome Diagnostics to develop and commercialize high-performance biofluid sample preparation kits for the processing of nucleic acids from exosomes. Combining Exosome Diagnostics’ platform technology approach with select Qiagen consumables and automation platforms has the potential to allow researchers, drug developers, and medical professionals to take repeated, real-time genetic “snapshots” of disease from patients’ blood, urine, or cerebrospinal fluid without the need for tissue biopsy. Qiagen’s exosome technology-driven kits will offer the ability to work with
Immunetics has received FDA clearance for its BacTx rapid test for bacteria in apheresis platelets. The BacTx system is a colorimetric assay that can detect aerobic, anaerobic, gram-negative, and gram-positive bacteria in a single test. The BacTx assay uses a patented, specific, universal bacterial detection reagent that has been shown to detect wild and cultured bacterial strains. BacTx is intended for use as a point-of-issue test performed at the transfusion site on the day of issue. The BacTx assay can
